Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 27/11/2020
SIETES contiene 93167 citas

 
 
 1 a 5 de 5 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, for the Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013;368:1489-97. [Ref.ID 95274]
2. Cita con resumen
Douketis J, Cook D, Meade M, Guyatt G, Geerts W, Skrobik Y, Albert M, Granton J, Hébert P, Pagliarello G, Marshall J, Fowler R, Freitag A, Rabbat C, Anderson D, Zytaruk N, Heels-Ansdell D, Crowther M, for the Canadian Critical Care Trials Group. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin. Arch Intern Med 2008;168:1805-12. [Ref.ID 84093]
3.
Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke R Z, Brun-Buisson C, for the Canadian Critical Care Trials Group. Incidence and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-40. [Ref.ID 40574]
4.
Cook D, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A, for the Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998;338:791-7. [Ref.ID 37263]
5. Cita con resumen
Cook DJ, Fuller HD, Guyatt GH, Marshall J C, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJR, Roy P, Lacroix J, Griffith L, Willian A, for the Canadian Critical Care Trials Group. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994;330:377-81. [Ref.ID 21119]
Seleccionar todas
 
 1 a 5 de 5